Page last updated: 2024-09-04

atrasentan and pd 98059

atrasentan has been researched along with pd 98059 in 1 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(pd 98059)
Trials
(pd 98059)
Recent Studies (post-2010) (pd 98059)
358411084,93931,001

Protein Interaction Comparison

ProteinTaxonomyatrasentan (IC50)pd 98059 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)2.8
Luciferin 4-monooxygenasePhotinus pyralis (common eastern firefly)6.3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)2.8
Prostaglandin G/H synthase 1Homo sapiens (human)1
Mitogen-activated protein kinase 1Homo sapiens (human)2.8
Dual specificity mitogen-activated protein kinase kinase 2 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callera, GE; Carneiro, FS; Carneiro, ZN; Ergul, A; Giachini, FR; Lima, VV; Tostes, RC; Webb, RC; Zemse, SM1

Other Studies

1 other study(ies) available for atrasentan and pd 98059

ArticleYear
Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:2

    Topics: Animals; Aorta; Atrasentan; Blood Pressure; Endothelin A Receptor Antagonists; Endothelin-1; Endothelins; Flavonoids; Humans; Infusion Pumps, Implantable; Interleukin-10; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Protein Kinase Inhibitors; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Recombinant Proteins; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Vasoconstriction

2009